Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OriolaCHIX:ORIOLH 38 Price-to-Tangible-Book is 3.74 as of Aug. 16, 2026, which is 67% above its 10-year median of 2.24. GuruFocus rates CHIX:ORIOLH with a GF Score™ of 38/100 and a GF Value™ of €0.73. The stock has 5 warning signs investors should review. Among 504 Healthcare Providers & Services companies, Oriola ranks worse than 58.93% on this metric.
As of today (2026-08-16), Oriola's share price is €0.938. Oriola's Tangible Book per Share of Jun. 2026 for the quarter that ended in Jun. 2026 was €0.25. Hence, Oriola's Price to Tangible Book Ratio of today is 3.74.
The historical rank and industry rank for Oriola's Price-to-Tangible-Book or its related term are showing as below:
CHIX:ORIOLh'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.45 Med: 2.24 Max: 3.71
Current: 3.61
During the past 13 years, Oriola's highest Price to Tangible Book Ratio was 3.71. The lowest was 1.45. And the median was 2.24.
CHIX:ORIOLh's Price-to-Tangible-Book is ranked worse than 58.93% of 504
companies
in the Healthcare Providers & Services industry
Industry Median: 2.665
vs CHIX:ORIOLh: 3.61
A closely related ratio is called PB Ratio. As of today, Oriola's share price is €0.938. Oriola's Book Value per Sharefor the quarter that ended in Jun. 2026 was €0.48. Hence, Oriola's P/B Ratio of today is 1.96.
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Oriola Price-to-Tangible-Book Related Terms
Oriola Price-to-Tangible-Book Historical Data
* Premium members only.
The historical data trend for Oriola's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Oriola's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oriola Price-to-Tangible-Book vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Oriola's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Oriola's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Oriola (CHIX:ORIOLH) has a Price-to-Tangible-Book of 3.74 as of Aug. 16, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Oriola and its competitors. This is 67% above median its historical median of 2.24. Over the past decade, Oriola's Price-to-Tangible-Book has ranged from 1.45 to 3.71. According to the industry distribution chart, Oriola ranks #297 out of 504 companies in the Healthcare Providers & Services industry, placing it in the top 58.9%.
Is Oriola's Price-to-Tangible-Book too high?
Oriola's current Price-to-Tangible-Book of 3.74 is 67% above median its 10-year median of 2.24. Over the past 10 years, this metric has ranged from a low of 1.45 to a high of 3.71. The Healthcare Providers & Services industry median Price-to-Tangible-Book is 2.67. Oriola's value of 3.74 is 40.3% above this industry median. Based on the distribution chart, Oriola ranks #297 out of 504 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Oriola has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Oriola's Price-to-Tangible-Book compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Oriola ranks #297 out of 504 companies for Price-to-Tangible-Book. This places Oriola in the lower half of its industry. The industry median Price-to-Tangible-Book is 2.67. Oriola's value of 3.74 is 40.3% above this benchmark. Historically, Oriola's own Price-to-Tangible-Book has ranged from 1.45 to 3.71 over the past decade. While the company's 10-year median is 2.24 vs. the industry median of 2.67, Oriola has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Healthcare Providers & Services company?
The median Price-to-Tangible-Book among Healthcare Providers & Services companies is 2.67, based on 504 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oriola's current Price-to-Tangible-Book of 3.74 is 40.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Oriola and its competitors. For the Healthcare Providers & Services industry, the median Price-to-Tangible-Book is 2.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oriola's current Price-to-Tangible-Book is 3.74, which is 67% above median its own 10-year median of 2.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oriola stock overvalued right now?
Oriola (CHIX:ORIOLH) has a current Price-to-Tangible-Book of 3.74. The stock's GF Value™ is €0.73, compared to a current price of €0.94 — trading 28.5% above its estimated fair value. The current Price-to-Tangible-Book is 3.74, which is 67% above median its 10-year median of 2.24 and 40.3% above the Healthcare Providers & Services industry median of 2.67. Oriola's overall GF Score™ is 38/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For Oriola (CHIX:ORIOLH), the current Price-to-Tangible-Book is 3.74 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oriola (CHIX:ORIOLH) Overvalued in 2026?
Based on GuruFocus' analysis, Oriola stock appears to be overvalued.
The current stock price of €0.94 is trading 28.5% above its estimated GF Value™ of €0.73.
Key valuation signals for CHIX:ORIOLH:
Price-to-Tangible-Book: 3.74 (67% above median its 10-year median of 2.24)
GF Value™: €0.73 vs. price of €0.94 (28.5% above fair value)
Industry Position: 40.3% above the Healthcare Providers & Services median (#297 of 504)
No single metric tells the full story. See the CHIX:ORIOLH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oriola Corp is a health and wellbeing company operating in Nordic countries. It offers services such as the distribution of pharmaceuticals and other health and well-being products, services, and dose dispensing. Oriola's operations are divided into two segments which include distribution and wholesale. Geographically, the company operates in Sweden, Finland and other countries generating majority revenue from the region of Sweden.
38GF Score
Get the complete analysis for CHIX:ORIOLH
Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:ORIOLH has been successfully added to your 
